Can a pain drug help you walk better with knee arthritis?

NCT ID NCT07759336

Not yet recruiting Symptom relief Sponsor: Benedict Alter Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether duloxetine, an FDA-approved osteoarthritis drug, can improve walking ability and physical activity in people with chronic knee osteoarthritis pain. Participants take duloxetine or a placebo for six weeks, then complete surveys, physical tasks, brain imaging, and sensory tests. The goal is to see if the drug helps with pain during movement and everyday function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Duloxetine, an FDA-approved drug for osteoarthritis, taken by mouth daily for 6 weeks.
What this could lead to: If effective, duloxetine could become a proven option to improve walking ability and daily activity in people with knee osteoarthritis.
What could go wrong: This is a relatively small trial, and duloxetine may not outperform placebo. Possible side effects include nausea, dizziness, and fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KNEE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KNEE PAIN CHRONIC PAIN KNEE OSTEOARTHRITIS (KNEE OA)

Contacts and locations

Locations

University of Pittsburgh - Center for Innovation in Pain Care (Research)

Pittsburgh, Pennsylvania, 15206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.